Management of common symptoms of advanced lung cancer

被引：2

作者：

Bedor M. ^{[1
]}

Alexander C. ^{[1
]}

Edelman M.J. ^{[1
]}

机构：

[1] University of Maryland, Greenebaum Cancer Center, Baltimore, MD 21201

来源：

Current Treatment Options in Oncology | 2005年 / 6卷 / 1期

关键词：

Lung Cancer; Cancer Pain; Salmeterol; Cancer Cachexia; Advanced Lung Cancer;

D O I：

10.1007/s11864-005-0013-2

中图分类号：

学科分类号：

摘要：

Disease-directed treatment of lung cancer reduces the morbidity and extends life for patients. However, as providers we must recognize that treating the symptoms of the disease may be as important as the treatment of the disease itself. This is particularly true in advanced disease and after disease-directed therapies have been exhausted. Aggressive assessment of symptoms and use of palliative therapies can significantly reduce the symptomatology of advanced lung cancer. Though the impact of these symptoms (ie, pain, dyspnea, and cachexia) are well known, they tend to be under-treated. In addition, simple maneuvers such as opiate rotation for pain relief are underutilized. The diagnosis of lung cancer and its associated symptoms may result in severe psychosocial stress for the patient and further exacerbate the symptoms in a vicious cycle. Understanding of coping strategies may aid the medical provider in assisting the patient during his or her illness. Copyright © 2005 by Current Science Inc.

引用

页码：61 / 68

页数：7

共 26 条

[1]

Thomas L., Kwok Y., Edelman M.J., Management of paraneoplastic syndromes in lung cancer, Curr. Treat. Options Oncol., 5, pp. 51-62, (2004)

[2]

Coyle N., Adelhardt J., Foley K.M., Portenoy R.K., Character of terminal illness in the advanced cancer patient: Pain and other symptoms during the last four weeks of life, J. Pain Symptom Manage., 5, pp. 83-93, (1990)

[3]

Porter L.S., Keefe F.J., McBride C.M., Perceptions of patients' self efficacy for managing pain and lung cancer symptoms: Correspondence between patients and family caregivers, Pain, 98, pp. 169-178, (2002)

[4]

Cleeland C.S., Cleeland L.M., Dar R., Rinehardt L.C., Factors influencing physician management of cancer pain, Cancer, 58, pp. 796-800, (1986)

[5]

Von Roenn J.H., Cleeland C.S., Gonin R., Physician attitudes and practice in cancer pain management, Ann. Intern. Med., 119, pp. 121-126, (1993)

[6]

Von Roenn J.H., Cleeland C.S., Gonin R., Physician attitudes and practice in cancer pain management: A survey from the Eastern Cooperative Oncology Group, Ann. Intern. Med., 119, pp. 121-126, (1993)

[7]

Silvestri G.A., Sherman C., Williams T., Caring for the dying patient with lung cancer, Chest, 122, pp. 1028-1036, (2002)

[8]

Watson P.N., Evans R.J., Intractable pain with lung cancer, Pain, 29, pp. 163-173, (1987)

[9]

Levy M., Pharmacologic management of cancer pain, Semin. Oncol., 21, pp. 718-739, (1994)

[10]

Mercandante S., Opioid rotation for cancer pain, Cancer, 86, pp. 1856-1866, (1999)

← 1 2 3 →